IBM Discloses Debt Maturities and Stock Information in 8-K Filing

TL;DR

**IBM just dropped an 8-K detailing its common stock and a bunch of notes maturing from 2024 to 2029, all traded on NYSE and CHX.**

AI Summary

International Business Machines Corp (IBM) filed an 8-K on February 26, 2024, disclosing information under Regulation FD and regarding financial statements and exhibits. The filing specifically mentions various notes due between 2024 and 2029, including 1.125% Notes Due 2024, 2.875% Notes Due 2025, and 0.300% Notes Due 2028, all traded on the NYSE. The common stock, with a par value of $.20 per share, is also noted as traded on the CHX and NYSE.

Why It Matters

This filing provides transparency on IBM's outstanding debt obligations and common stock details, which is crucial for investors to assess the company's financial health and capital structure.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of existing financial instruments and does not indicate new risks or significant changes.

Key Numbers

• $.20 — Common Stock Par Value (Per share par value of IBM's common stock)
• 1.125% — Notes Interest Rate (Interest rate for Notes Due 2024)
• 2.875% — Notes Interest Rate (Interest rate for Notes Due 2025)
• 0.300% — Notes Interest Rate (Interest rate for Notes Due 2026 and 2028)
• 1.500% — Notes Interest Rate (Interest rate for Notes Due 2029)

Key Players & Entities

• INTERNATIONAL BUSINESS MACHINES CORP (company) — Filer of the 8-K
• IBM (company) — Ticker for International Business Machines Corp
• $0.20 (dollar_amount) — Par value per share of common stock
• 2024 (date) — Maturity year for 1.125% Notes
• 2025 (date) — Maturity year for 2.875%, 0.950%, and 0.875% Notes
• 2026 (date) — Maturity year for 0.300% Notes
• 2027 (date) — Maturity year for 1.250% and 3.375% Notes
• 2028 (date) — Maturity year for 0.300% and 1.750% Notes
• 2029 (date) — Maturity year for 1.500% Notes

FAQ

Filing Documents

• tm247131d1_8k.htm (8-K) — 93KB
• tm247131d1_ex99-1.htm (EX-99.1) — 10KB
• 0001104659-24-027204.txt ( ) — 469KB
• ibm-20240226.xsd (EX-101.SCH) — 8KB
• ibm-20240226_def.xml (EX-101.DEF) — 37KB
• ibm-20240226_lab.xml (EX-101.LAB) — 51KB
• ibm-20240226_pre.xml (EX-101.PRE) — 35KB
• tm247131d1_8k_htm.xml (XML) — 34KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On February 26, 2024, IBM announced that it is updating its reporting segments in the first quarter of 2024. Exhibit 99.1 of this Form 8-K contains additional information that the Company posted on its Investor Relations website (www.ibm.com/investor/) about these updates. The information in this Item 7.01, including Exhibit 99.1, is being furnished with the Commission and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits The following exhibit is being furnished as part of this report: Exhibit No. Description of Exhibit 99.1 Investor Relations Article, dated February 26, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) IBM's web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit its various web sites from time to time, as information is updated and new information is posted. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Date: February 26, 2024 By: /s/ Nicols Fehring Nicols Fehring Vice President and Controller 3

View Full Filing

View this 8-K filing on SEC EDGAR